November 28, 2024 - 08:51

In a significant move, former President Donald Trump has selected a Stanford University professor known for his critical stance on COVID-19 lockdowns to lead a key health agency. This appointment comes as part of Trump’s ongoing efforts to reshape health policy and address public health challenges in the wake of the pandemic. The professor, who has gained attention for advocating against strict lockdown measures, is expected to bring a controversial perspective to the role.
Before officially assuming the position, the appointee will need to secure confirmation from the U.S. Senate, a process that could spark intense debate given the professor's previous comments and the current political climate surrounding public health policies. Trump's choice reflects his commitment to appointing individuals who align with his views on government intervention and public health measures. As the nation continues to navigate the complexities of health care and pandemic response, this appointment is poised to influence future strategies and discussions within the health sector.
March 20, 2026 - 02:52
By studying muscle function, student aims to improve others’ physical health—and maybe his own | Harvard T.H. Chan School of Public HealthSam Lapp, a dedicated PhD candidate, is on a scientific mission to unlock the secrets of muscle function. His research at the intersection of biology and public health aims to translate complex...
March 19, 2026 - 01:11
Urgent public health alert as Kent meningitis outbreak growsHealth authorities have escalated warnings following a growing outbreak of invasive meningococcal disease in Kent, England. Officials are urging heightened vigilance as the number of confirmed...
March 18, 2026 - 01:26
Minnesota's Allina Health merges with Sutter HealthIn a significant move set to reshape the nonprofit healthcare landscape, Minnesota-based Allina Health has signed a Letter of Intent to merge with California`s Sutter Health. The agreement will see...
March 17, 2026 - 12:26
White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool receptionDespite facing a notably cool reception on Capitol Hill, the Biden administration is digging in its heels and ramping up pressure on Congress to pass a transformative drug pricing measure. The...